Overview
Joel Hirschhorn is a Pediatric Endocrinologist in Boston, Massachusetts. Dr. Hirschhorn is rated as an Advanced provider by MediFind in the treatment of Hypoaldosteronism. His top areas of expertise are Obesity, Short Stature (Growth Disorders), Neurohypophyseal Diabetes Insipidus, and Diabetes Insipidus (DI).
His clinical research consists of co-authoring 215 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hypoaldosteronism.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
Locations
Additional Areas of Focus
Dr. Hirschhorn has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Svetlana Azova is a Pediatric Endocrinologist in Boston, Massachusetts. Dr. Azova is rated as an Advanced provider by MediFind in the treatment of Hypoaldosteronism. Her top areas of expertise are Hypoaldosteronism, Type 1 Diabetes (T1D), Diabetic Ketoacidosis, and Precocious Puberty.
Nora Renthal is a Pediatric Endocrinologist in Boston, Massachusetts. Dr. Renthal is rated as an Advanced provider by MediFind in the treatment of Hypoaldosteronism. Her top areas of expertise are Hypoaldosteronism, Familial Glucocorticoid Deficiency, Triple A Syndrome, and Juvenile Primary Osteoporosis.
David Breault is a Pediatric Endocrinologist in Boston, Massachusetts. Dr. Breault is rated as an Advanced provider by MediFind in the treatment of Hypoaldosteronism. His top areas of expertise are Congenital Adrenal Hyperplasia (CAH), Familial Glucocorticoid Deficiency, Hypoaldosteronism, and Triple A Syndrome.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- ObesityDr. Hirschhorn isElite. Learn about Obesity.
- Distinguished
- Short Stature (Growth Disorders)Dr. Hirschhorn isDistinguished. Learn about Short Stature (Growth Disorders).
- Advanced
- Diabetes Insipidus (DI)Dr. Hirschhorn isAdvanced. Learn about Diabetes Insipidus (DI).
- HypoaldosteronismDr. Hirschhorn isAdvanced. Learn about Hypoaldosteronism.
- HypogonadismDr. Hirschhorn isAdvanced. Learn about Hypogonadism.
- Hypogonadotropic HypogonadismDr. Hirschhorn isAdvanced. Learn about Hypogonadotropic Hypogonadism.
- Neurohypophyseal Diabetes InsipidusDr. Hirschhorn isAdvanced. Learn about Neurohypophyseal Diabetes Insipidus.
- Pediatric Growth Hormone DeficiencyDr. Hirschhorn isAdvanced. Learn about Pediatric Growth Hormone Deficiency.
- Experienced
- Addison's DiseaseDr. Hirschhorn isExperienced. Learn about Addison's Disease.
- Cardiofaciocutaneous SyndromeDr. Hirschhorn isExperienced. Learn about Cardiofaciocutaneous Syndrome.
- Cardiomyopathic LentiginosisDr. Hirschhorn isExperienced. Learn about Cardiomyopathic Lentiginosis.
- Congenital HyperinsulinismDr. Hirschhorn isExperienced. Learn about Congenital Hyperinsulinism.
- Congenital HypothyroidismDr. Hirschhorn isExperienced. Learn about Congenital Hypothyroidism.
- End-Stage Renal Disease (ESRD)Dr. Hirschhorn isExperienced. Learn about End-Stage Renal Disease (ESRD).